HK1146722A1 - Equilibrative nucleoside transporter ent1 inhibitors - Google Patents

Equilibrative nucleoside transporter ent1 inhibitors

Info

Publication number
HK1146722A1
HK1146722A1 HK11100813.2A HK11100813A HK1146722A1 HK 1146722 A1 HK1146722 A1 HK 1146722A1 HK 11100813 A HK11100813 A HK 11100813A HK 1146722 A1 HK1146722 A1 HK 1146722A1
Authority
HK
Hong Kong
Prior art keywords
nucleoside transporter
equilibrative nucleoside
inhibitors
transporter ent1
ent1 inhibitors
Prior art date
Application number
HK11100813.2A
Other languages
English (en)
Inventor
Jean-Paul Rene Marie Andre Bosmans
Didier Jean-Claude Berthelot
Serge Maria Aloysius Pieters
Bie Maria Pieter Verbist
Cleyn Michel Anna Jozef De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1146722A1 publication Critical patent/HK1146722A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
HK11100813.2A 2007-11-14 2011-01-26 Equilibrative nucleoside transporter ent1 inhibitors HK1146722A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07120630 2007-11-14
PCT/EP2008/065438 WO2009062990A2 (en) 2007-11-14 2008-11-13 Equilibrative nucleoside transporter ent1 inhibitors

Publications (1)

Publication Number Publication Date
HK1146722A1 true HK1146722A1 (en) 2011-07-08

Family

ID=39145373

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11100813.2A HK1146722A1 (en) 2007-11-14 2011-01-26 Equilibrative nucleoside transporter ent1 inhibitors

Country Status (18)

Country Link
US (1) US8263592B2 (pt)
EP (1) EP2209790B1 (pt)
JP (1) JP5369108B2 (pt)
KR (1) KR101598136B1 (pt)
CN (1) CN101855224B (pt)
AR (1) AR069304A1 (pt)
AU (1) AU2008322960B2 (pt)
BR (1) BRPI0820642B1 (pt)
CA (1) CA2704423C (pt)
CL (1) CL2008003383A1 (pt)
EA (1) EA017215B1 (pt)
ES (1) ES2569511T3 (pt)
HK (1) HK1146722A1 (pt)
IL (1) IL205710A (pt)
JO (1) JO3126B1 (pt)
PA (1) PA8803401A1 (pt)
TW (1) TWI437000B (pt)
WO (1) WO2009062990A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201101959D0 (en) 2011-02-04 2011-03-23 Univ Nottingham Novel ether linked compoundsand improved treatments for cardiac and cardiovascular disease
AU2015279377B2 (en) 2014-06-26 2019-09-12 F. Hoffmann-La Roche Ag Indolin-2-one or pyrrolo-pyridin-2-one derivatives
CN108349942B (zh) 2015-11-06 2021-03-30 豪夫迈·罗氏有限公司 用于治疗cns和相关疾病的二氢吲哚-2-酮衍生物
WO2017076842A1 (en) * 2015-11-06 2017-05-11 F. Hoffmann-La Roche Ag Indolin-2-one derivatives
CA3002489C (en) 2015-11-06 2023-11-07 F.Hoffmann-La Roche Ag Indolin-2-one derivatives
CN105802999B (zh) * 2016-04-01 2019-05-03 中南大学湘雅医院 一种膜蛋白ENTs跨膜转运ODNs的试剂盒及方法
JP6879677B2 (ja) 2016-05-26 2021-06-02 株式会社クボタ 作業車
TW201817726A (zh) 2016-11-14 2018-05-16 大陸商江蘇恆瑞醫藥股份有限公司 ３，４－二吡啶基吡唑類衍生物、其製備方法及其在醫藥上的應用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701396D0 (sv) * 1997-04-15 1997-04-15 Astra Pharma Prod Compounds
GB0003397D0 (en) * 2000-02-14 2000-04-05 Merck Sharp & Dohme Therapeutic agents
WO2004060902A2 (en) * 2002-12-31 2004-07-22 John K Buolamwini Novel nucleoside transport inhibitors
JPWO2004101593A1 (ja) * 2003-05-16 2006-07-13 キッセイ薬品工業株式会社 ５’−修飾ヌクレオシド誘導体及びその医薬用途
ES2377937T3 (es) * 2003-12-26 2012-04-03 Kissei Pharmaceutical Co., Ltd. Derivados de benzimidazol y usos médicos de los mismos
WO2007011815A2 (en) 2005-07-15 2007-01-25 Children's Hospital Medical Center Apparatus for minimally invasive posterior correction of spinal deformity
TW200804393A (en) * 2005-11-14 2008-01-16 Solvay Pharm Gmbh Novel N-sulfamoyl-N'-benzopyranpiperidines for medical use
US7576207B2 (en) * 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use

Also Published As

Publication number Publication date
BRPI0820642A2 (pt) 2020-08-11
US20100280025A1 (en) 2010-11-04
US8263592B2 (en) 2012-09-11
CA2704423C (en) 2017-01-10
BRPI0820642B1 (pt) 2021-05-25
WO2009062990A2 (en) 2009-05-22
IL205710A0 (en) 2010-11-30
AR069304A1 (es) 2010-01-13
CL2008003383A1 (es) 2010-02-05
ES2569511T3 (es) 2016-05-11
EA201070599A1 (ru) 2010-12-30
CN101855224B (zh) 2012-11-28
WO2009062990A3 (en) 2009-09-24
CA2704423A1 (en) 2009-05-22
JP5369108B2 (ja) 2013-12-18
CN101855224A (zh) 2010-10-06
KR101598136B1 (ko) 2016-02-29
EA017215B1 (ru) 2012-10-30
JO3126B1 (ar) 2017-09-20
EP2209790B1 (en) 2016-02-17
EP2209790A2 (en) 2010-07-28
TW200936593A (en) 2009-09-01
JP2011503147A (ja) 2011-01-27
TWI437000B (zh) 2014-05-11
PA8803401A1 (es) 2009-06-23
AU2008322960A1 (en) 2009-05-22
KR20100089088A (ko) 2010-08-11
IL205710A (en) 2013-07-31
AU2008322960B2 (en) 2013-02-07

Similar Documents

Publication Publication Date Title
IL213698A0 (en) Nucleoside phosphoramidates
IL205518A0 (en) Distributed netork for performing complex algorithms
ZA201008829B (en) Nucleoside cyclicphosphates
IL201379A0 (en) Inhibitors iap
DK200800103A (en) Integreret føringskant for vindturbineblad
EP2185745A4 (en) THERMOCOUPLE
EP2196131A4 (en) INTRODUCTION SYSTEM IN A SUBJECT
EP2160129A4 (en) FOR ADJUSTING TURNING CATHETERIZATION SYSTEM
ZA201003438B (en) Antiviral nucleoside compounds
HK1176601A1 (zh) 抑制劑
EP2225667A4 (en) REAL TIME COMMENTARY UNIT
EP2069956A4 (en) CENTRAL TV SYSTEM
GB0718255D0 (en) Nucleobase characterisation
HK1146722A1 (en) Equilibrative nucleoside transporter ent1 inhibitors
GB0710995D0 (en) Combines
GB0710994D0 (en) Combines
EP2029448A4 (en) TRANSPORT APPARATUS
EP2023727A4 (en) PROSTAGLANDINTRANSPORTER INHIBITORS
GB0709061D0 (en) Expression system
GB0711032D0 (en) Combines
DK200901203A (en) Hydroponisk system
EP2222662A4 (en) INHIBITORS OF KYNURENINE AMINO TRANSFERASE
HK1187256A1 (en) Anti-hypertensive agent
TWM319832U (en) Improved structure for pliers
HK1147354A1 (en) Two-power-source system

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20221115